Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: Rationale and design

EuroIntervention

Volumn 6, Issue 9, 2011, Pages 1117-1122

  Briguori, Carlo ^a   Visconti, Gabriella ^a   Ricciardelli, Bruno ^a   Condorelli, Gerolama ^b  

^a Clinica Mediterranea   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Complication; Contrast media; Kidney; Prevention

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; FUROSEMIDE; IODIXANOL; BIOLOGICAL MARKER; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DIURETIC AGENT; IODOBENZOIC ACID DERIVATIVE;

ADULT; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR PROCEDURES; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE THERAPY; DRUG ELIMINATION; DRUG INFUSION; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; URINE VOLUME; ACUTE KIDNEY FAILURE; BLOOD; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; EQUIPMENT DESIGN; INSTRUMENTATION; INTERVENTIONAL RADIOLOGY; ITALY; KIDNEY DISEASE; KIDNEY FAILURE; META ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR; TIME; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONTRAST MEDIA; CREATININE; DIURETICS; DRUG THERAPY, COMBINATION; EQUIPMENT DESIGN; FLUID THERAPY; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HUMANS; ITALY; KIDNEY DISEASES; RADIOGRAPHY, INTERVENTIONAL; RENAL INSUFFICIENCY; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SODIUM BICARBONATE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS;

EID: 80051631028     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I9A194     Document Type: Article

References (24)

1. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-1428. (Pubitemid 351471786)
2. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113:1799-1806. (Pubitemid 43958473)
3. Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010;121:2117-2122.
4. Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 2009;122:874 e9-15.
5. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Eng J Med 2000;343:180-184. (Pubitemid 30489215)
6. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-2334. (Pubitemid 38656299)
7. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211-1217. (Pubitemid 46594764)
8. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, O'Neill WW. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol. 1999;33:403-411. (Pubitemid 29234202)
9. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Eng J Med 1994;331:1416-1420. (Pubitemid 24348355)
10. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron. 1992;62:413-415.
11. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol. 2008;3:481-490.
12. Bonventre JV. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol. 2007;156:213-219.
13. Resnic FS, Davidson C, Zelman R, Dorval JF, Dixon SM. Prevention of contrast induced nephropathy using high volume matched diuresis using the RenalGuard System: first-in-man study. J Am Coll Cardiol 2009;53: A35.
14. Marenzi G, Cristina Ferrari, Emilio Assanelli, Ivana Marana, Gianfranco Lauri, Monica De Metrio, Marco Grazi, Giovanni Teruzzi, Daniela Trabattoni, and Antonio L Bartorelli. Furosemide-induced diuresis with matched hydration compared to standard hydration for contrast-induced nephropathy prevention: preliminary results of the MYTHOS trial. Circulation 2009;120:S1003.
15. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
16. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc. 2009;107:403-405.
17. Anello C, O'Neill RT, Dubey S. Multicentre trials: a US regulatory perspective. Stat Methods Med Res. 2005;14:303-318. (Pubitemid 40797030)
18. Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2004;25:206-211. (Pubitemid 38235156)
19. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
20. Kellum JA, Bellomo R, Ronco C, Mehta R, Clark W, Levin NW. The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs 2005;28:441-444. (Pubitemid 40823643)
21. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20:672-679.
22. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-1399. (Pubitemid 39303939)
23. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Eng I Med. 2003;349:1333-1340. (Pubitemid 37186211)
24. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82-292